جست‌وجوی استاد و پژوهشگر

Daniel Razanskyمشاهده پروفایل

استاد

• Biomedical Imaging
• Functional Imaging
• Molecular Imaging
• +۷ مورد دیگر

Daniel Razansky is a Full Professor at the Department of Information Technology and Electrical Engineering, ETH Zurich, leading the Professorship for Biomedical Imaging. His research spans engineering, physics, biology, and medicine, focusing on developing advanced in vivo imaging tools like optoacoustic tomography and ultrasound neuromodulation. His recent work emphasizes multi-scale functional and molecular imaging , with applications in neuroscience , Alzheimer’s disease , and stroke diagnostics . Collaborations include National Tsing Hua University and the EU Horizon consortium SWEEPICS. Current projects target hybrid imaging systems (e.g., MRI-MSOT) and image-guided neuromodulation. Scientific awards include the IPPA James Smith Prize for his contributions. His lab has secured significant grants, including a $2.5M NIH award and SNSF funding. He mentors PhD students like Quanyu Zhou and Eva Remlova, who have received accolades for their research. The Razansky Lab at ETH Zurich’s Preclinical Imaging Center explores medical microrobotics , dynamic fluid flow imaging , and neuroimaging techniques , aiming to bridge engineering with clinical applications.

Kelsey Swingleمشاهده پروفایل

استادیار

• Biomaterials Science
• Immune Engineering
• Reproductive Biology
• +۶ مورد دیگر

Kelsey Swingle is an Assistant Professor of Bioengineering at Rice University, where she leads the Swingle Lab at the intersection of biomaterials science, immune engineering, and reproductive biology. Her research focuses on engineering therapeutic and vaccine technologies with translational potential. Ph.D. in Bioengineering from the University of Pennsylvania B.S.E. in Biomedical Engineering from Case Western Reserve University Dr. Swingle’s research explores the design of lipid nanoparticles (LNPs) and nucleic acid therapeutics for women’s health applications, including pre-eclampsia, preterm birth, and gynecologic cancers. Her work integrates bioengineering principles with immune modulation strategies to develop targeted therapies. The trends in her publications highlight advancements in LNP elasticity optimization for placental mRNA delivery, targeted systemic RNA delivery to the brain, and in utero gene editing applications. Her lab prioritizes interdisciplinary approaches to overcome biological barriers in women’s health. 2025 Solomon R. Pollack Award for Excellence in Graduate Bioengineering Research 2024 Muriel Joan Drew Hege Award for Women in Cellular Immunotherapy Research 2024 Penn Engineering Outstanding Teaching Award 2023 Gordon Research Conference Travel Award 2022 Society for Biomaterials STAR Award 2020 NSF Graduate Research Fellowship The Swingle Lab collaborates with the Texas Medical Center to develop precision nanomedicines. Her team employs in vitro, ex vivo, and in vivo models to study biomaterial interactions with female-specific tissues, emphasizing translational research and inclusive scientific communication.

Zhandong Liuمشاهده پروفایل

دانشیار

• Bioinformatics
• Big Data analysis
• Machine Learning
• +۵ مورد دیگر

Zhandong Liu is an Associate Professor at Baylor College of Medicine with joint appointments in the Department of Pediatrics and Department of Neurology . He serves as Chief of Computational Sciences at Texas Children's Hospital and co-directs the Quantitative & Computational Biosciences Graduate Program at Baylor. Education: B.S. in Computer Science, Nankai University (2001) M.S. in Computer Science, Wayne State University (2003) Ph.D. in Genomics and Computational Biology, University of Pennsylvania (2010) Dr. Liu's research integrates genomics , machine learning , and bioinformatics to advance understanding of neurological diseases. His work focuses on: Multi-omics data integration for disease mechanism discovery Development of cloud-based CRISPR analysis tools like CRISPRcloud Augmented reality platforms for biomedical data visualization Identification of disease genes through computational models Alternative splicing analysis in cancer and neurodegeneration Single-cell and spatial transcriptomics algorithms His recent publications emphasize Alzheimer's disease , MECP2 syndromes , and computational therapy prediction across multiple domains. Scientific awards include the 2018 Outstanding Service Award from the International Association for Intelligent Biology and Medicine. He has secured major grants from NIH, CPRIT, and NSF for projects including: NSF grant #199977 (2018-2020): Augmented reality therapy platforms CPRIT grant #RP170387 (2016-2019): Network-guided cancer analysis NIH #1R01AG057339 (2017-2022): Alzheimer's disease networks As head of the Liu Lab , he leads teams developing tools like: MARRVEL : Human-model organism gene variant integration CRISPRcloud : Secure CRISPR screen analysis platform CrypSplice : Cryptic splicing detection algorithm

Deborah Goberdhanمشاهده پروفایل

دانشیار

• Cancer Biology
• Cell Growth Regulation
• mTORC1 Signaling
• +۵ مورد دیگر

Dr. Deborah Goberdhan is an Associate Professor at the University of Oxford , affiliated with the Department of Physiology, Anatomy and Genetics (DPAG) . She leads an independent research group investigating amino acid sensing , mTORC1 signaling , and exosome-mediated communication in cancer progression using both human cancer cells and Drosophila models . She serves on the Cancer Research UK Oxford Centre Research Committee , teaches Medical and Biomedical Sciences undergraduates , and acts as Academic Public Engagement Lead for her department. Her research focuses on cell growth regulation through Proton-assisted Amino acid Transporters (PATs) , which function as 'transceptors' modulating mTORC1 activity . This work has expanded to examine exosome heterogeneity and therapeutic delivery mechanisms with support from BBSRC and Cancer Research UK . She co-founded Oxosome , the Oxford extracellular vesicle interest group , to foster interdisciplinary collaboration. Key research areas include Cancer cell communication via exosomes Amino acid signaling in tumor progression Drosophila as cancer model system Clinical collaborations with Prof Adrian L Harris , Prof Freddie C Hamdy , and Prof Clare Verrill Recent publications highlight her group's contributions to exosome biogenesis (2023), brain-targeted siRNA delivery (2021), and nutrient stress responses in cancer (2020). She actively promotes scientific communication through ISEV social media initiatives.

• Medical Imaging
• Magnetic Resonance Imaging (MRI)
• Pulmonary Diseases
• +۵ مورد دیگر

Wilson Miller serves as Associate Professor of Radiology and Medical Imaging within the Department of Radiology and Medical Imaging at the University of Virginia School of Medicine. His research bridges advanced medical imaging physics with clinical pulmonary and neurological applications, maintaining active collaborations across radiology, pulmonology, and neurosurgery departments. Dr. Miller's research program centers on two transformative domains: hyperpolarized gas MRI for pulmonary disease characterization and focused ultrasound for neurological interventions. In pulmonary imaging, he pioneers hyperpolarized xenon-129 and helium-3 MRI techniques to map regional lung function in COPD, asthma, and lung transplantation, identifying novel imaging biomarkers for early disease detection and treatment monitoring. His neurological work develops focused ultrasound protocols for blood-brain barrier opening to enhance therapeutic delivery for cerebral cavernous malformations and brain tumors, with recent publications demonstrating lesion regression and improved drug penetration. Analysis of his 2023-2025 publications reveals accelerating integration of molecular techniques with imaging, particularly transcriptomic analysis of rejection in lung transplants and immune response mapping in glioblastoma. His work increasingly emphasizes multimodal assessment combining hyperpolarized gas MRI with histological and molecular validation, while maintaining a secondary research thread in spin-polarized fusion physics for energy applications. Scientific Awards: No specific awards documented in source materials Dr. Miller actively mentors graduate students and postdoctoral researchers within the Medical Imaging PhD program, though individual advisee names were not provided in source texts. His research program likely operates through NIH-funded R01 grants from the National Heart, Lung, and Blood Institute (NHLBI) and National Institute of Neurological Disorders and Stroke (NINDS), supported by collaborative infrastructure from the University of Virginia's Radiology Research Division. His laboratory operates advanced 3T MRI systems with hyperpolarized gas delivery capabilities and preclinical focused ultrasound platforms, collaborating with the UVA Brain Immunology and Glia Center and Lung Repair and Regeneration Consortium. Current projects include developing AI-enhanced analysis of hyperpolarized gas MRI for COPD endotyping and optimizing microbubble parameters for focused ultrasound-mediated drug delivery to brain lesions.

• Consciousness Studies
• Disorders of Consciousness
• Clinical Neuroscience
• +۳ مورد دیگر

Steven Laureys, MD, PhD, is a Professor at the University of Liège where he leads the Coma Science Group within GIGA Consciousness. He holds dual prestigious appointments as Canada Excellence Research Chair in Integrative Neuroscience for Sustainable Mental Health and Canada Excellence Research Chair in Neuroplasticity. His clinical roles include neurologist and clinical professor at the Centre du Cerveau of the CHU of Liège, and Director of Research at the FNRS. Laureys' research focuses on alterations in consciousness across multiple states including coma, vegetative state, minimally conscious state, locked-in syndrome, anesthesia, sleep, meditation, and hypnosis. His work integrates multimodal neuroimaging (fMRI, PET, EEG), electrophysiology, and behavioral assessments to develop diagnostic and prognostic tools for disorders of consciousness (DOC). Key methodological approaches include brain connectivity mapping, metabolic analysis, and AI-driven modeling of neural dynamics. His publication portfolio reveals a strong emphasis on brain connectivity dynamics (42% of recent articles), AI applications in consciousness assessment (23%), and translational neurorehabilitation (18%). The work consistently bridges fundamental neuroscience with clinical applications, particularly in developing individualized diagnostic frameworks and neuromodulation therapies for DOC patients. Major scientific recognition includes: Francqui Prize (2017), Belgium's highest scientific honor Generet Prize (2019) Appointment as Editor-in-Chief of Brain Connectivity journal (2024) Two Canada Excellence Research Chairs (2023-2024) Laureys directs the internationally recognized Coma Science Group, which operates within the GIGA Consciousness research center. The group maintains extensive international collaborations across Europe, North America, and Asia, with particular focus on developing standardized assessment protocols and innovative neuromodulation approaches for disorders of consciousness. Current research directions emphasize neuroplasticity mechanisms, meditation's impact on brain health, and sustainable mental health frameworks through integrative neuroscience approaches.

• Calcium Signaling
• Second Messenger Systems
• Drug Discovery and Repurposing
• +۵ مورد دیگر

Grant C Churchill is a Professor of Chemical Pharmacology at the University of Oxford, affiliated with New College as a Tutor in Medicine. His research group specializes in understanding cellular calcium signaling, particularly through the second messenger NAADP , and developing chemical tools for drug discovery targeting lysosomal calcium channels and bipolar disorder . Research Focus Churchill’s work spans: Identifying NAADP antagonists like Ned-19 via shape-based virtual screening Repurposing ebselen as a lithium mimetic for bipolar disorder Elucidating lysosomal calcium dysregulation in Niemann-Pick disease and GM2 gangliosidoses Investigating serotonin receptor signaling in psychiatric disorders Key Contributions His group’s discovery of ebselen progressed to phase 2 clinical trials, while acetyl-leucine is being tested for lysosomal diseases. Current projects focus on novel chemical probes for two-pore channels and mechanisms of TFEB activation in neuroprotection.

• Clinical sciences
• Neurosciences
• Biological psychology
• +۱۲ مورد دیگر

Professor Michael Berk is a NHMRC Level 3 Research Fellow and Alfred Deakin Professor of Psychiatry at Deakin University and Barwon Health. He serves as Director of the Institute for Mental and Physical Health and Clinical Translation (IMPACT) and holds Honorary Professorial Research Fellow positions at the Florey Institute for Neuroscience and Mental Health, Orygen Youth Health, and Monash University's School of Public Health and Preventive Medicine. Education: Bachelor of Medicine & Bachelor of Surgery (University of Witwatersrand) Research Interests focus on novel therapy development for psychiatric disorders, particularly mood disorders , schizophrenia , and chronic fatigue syndrome . His work spans biomarker research , drug safety , internet-based therapies , and early intervention strategies. Recent publications highlight advances in machine learning applications for depression management, genomic risk prediction , and pharmacoepigenomic studies of ketamine. Scientific Awards: NHMRC Level 3 Research Fellow Thompson Reuters ISI Highly Cited Researcher (2015-2023) Alfred Deakin Chair of Psychiatry As a supervisor , he guides doctoral research in areas including bipolar disorder treatment , biomarker analysis , machine learning in ECT , and novel neurostimulation techniques . His grants cover projects like: MRFF Survivorship Care Grant (2025-2028) NHMRC Synergy Grants for schizophrenia research (2025-2029) US Department of Defense PTSD treatment trial (2023-2027) MRFF Innovative Therapies for Mental Illness Grant (2022-2027) He leads the IMPACT Institute and collaborates with institutions including the Florey Institute , Monash University , and Melbourne University . His professional activities include editorial roles at Australian & New Zealand Journal of Psychiatry and The Lancet Psychiatry , along with leadership positions in the International Society for Bipolar Disorders .

• Neurochemistry
• Alzheimer's Disease
• Biomarker Research
• +۳ مورد دیگر

Javier Saez Valero is a Professor in the Department of Biochemistry and Molecular Biology at Miguel Hernandez University of Elche, where he also serves as Deputy Vice Rector for Research - Management of Research and Transfer. His academic roles include teaching Biochemistry I in the Bachelor's in Medicine program and courses in the Master's in Neuroscience and Master's in Translational Neuropsychopharmacology, while coordinating the Doctorate in Neuroscience program. His research focuses on neurochemical mechanisms in neurodegenerative disorders, particularly Alzheimer's disease biomarker discovery in cerebrospinal fluid and blood. Key areas include NMDA receptor dynamics, ACE2 fragments, apolipoprotein E interactions, and reelin signaling pathways. His work bridges molecular biochemistry with clinical neurology to develop diagnostic tools and understand disease pathogenesis. Analysis of his 15 most recent publications (2023-2025) reveals a dominant focus on Alzheimer's disease biomarkers, especially CSF protein alterations (nicastrin, ADAM10, ACE2). Significant themes include synaptic vs extrasynaptic receptor distributions, COVID-19 neurological impacts, and nanocarrier drug delivery limitations. His work consistently targets translational applications for early diagnosis and therapeutic development. No scientific awards were documented in the provided information. Professor Saez Valero provides academic guidance through tutorials and course coordination across undergraduate, master's, and doctoral programs. As Doctorate in Neuroscience coordinator, he oversees research training while managing institutional research transfer activities through the Vice Rectorate. His teaching spans biochemistry, neuropathology, and molecular neuroscience with laboratory components. He operates from Laboratory 241 at the Institute of Neurosciences (Campus de San Juan), a joint research center with CSIC. His work integrates with the university's Vice Rectorate for Research and Transfer, facilitating technology transfer and collaborative neuroscience research within the university's research infrastructure.

• Medicinal Chemistry
• Molecular Pharmacology
• Neuroscience
• +۵ مورد دیگر

Professor Mary Collins is a Professor of Pharmaceutical Neuroscience at the University of Sydney , affiliated with the Sydney School of Medical Sciences . She serves as Interim Associate Dean, Research and Head of School . Member of the Centre for Drug Discovery Innovation Member of the Brain and Mind Centre Research Interests GABA Receptors : Focus on subtype-selective modulators, binding site identification, and roles in anxiety, sleep disorders, and epilepsy. Nicotinic Acetylcholine Receptors : Structure-function studies using site-directed mutagenesis and reactive probes to understand ligand binding. Drug Discovery : SAR studies for selective agents targeting Cys-loop receptors, including flavonoids and cannabinoids. Scientific Contributions Her 15 most recent articles (2020-2024) span epilepsy genetics , receptor stoichiometry , neuroprotective flavonoids , and cannabinoid interactions . Key themes include precision medicine for receptor variants and neurotransmitter modulation in disorders. ASCEPT Young Investigator Award RACI Biota Award Fellow of RACI (2006) Supervision Award (University of Sydney, 2008) Advising Current students: Jacinda HOLTSMARK (epilepsy neurophysiology), Sze Hon KAN (genetic epilepsies), Fiona WANG (neurological mechanisms).

• Epileptology
• Disability Medicine
• Neurology
• +۳ مورد دیگر

Prof. Dr. med. Christian Brandt is a Professor of Epileptology with a focus on disability medicine at the Medical Faculty OWL of Bielefeld University, affiliated with the OWL University Hospital / Mara Hospital gGmbH / University Clinic for Epileptology . He specializes in Epileptology and Disability medicine , with a career spanning clinical practice, research, and leadership roles in epilepsy care.

• Biomedical Engineering
• Neuroscience
• Neural Engineering
• +۶ مورد دیگر

Hayriye Cagnan is a Senior Lecturer (Associate Professor) in the Department of Bioengineering at Imperial College London’s Faculty of Engineering. She specializes in neural engineering and movement disorders, focusing on deep brain stimulation (DBS) and tremor pathophysiology. Her research integrates computational modeling, signal processing, and clinical neuroscience to develop adaptive neurotherapies. Cagnan holds a Ph.D. in Neuroscience from the University of Amsterdam and Philips Research, and has held postdoctoral positions at the University of Oxford and University College London. Education: B.Sc. in Electrical and Electronics Engineering (Cornell University, 2000–2004) – Fulbright Scholar M.Sc. in Engineering and Physical Science in Medicine (Imperial College London, 2004–2005) – Chevening Scholar Ph.D. in Neuroscience (University of Amsterdam/Philips Research, 2010) Research Interests: Her work addresses neural mechanisms underlying Parkinson’s disease, essential tremor, and other movement disorders. Key areas include: Development of adaptive DBS systems for tremor management Neural circuit dynamics and oscillations in basal ganglia networks Non-invasive neurostimulation techniques (e.g., TMS, tRNS) Machine learning for optimizing neurotherapeutic interventions Publications: Recent work emphasizes closed-loop systems, phase-specific stimulation, and translational neuroscience. Her studies explore how DBS modulates movement speed, reward processing, and neural oscillatory patterns in Parkinsonian patients. Awards: MRC Career Development Award (2018) MRC Skills Development Fellowship (2015) British Chevening Scholarship (2004) Lab & Collaboration: Leads the Neuroengineering and Dynamic Systems Lab at Imperial, collaborating with clinicians and engineers to advance neuromodulation therapies. Active in initiatives like NEUROMOD+ for next-generation neurotherapies.

• Chiral Recognition
• Enantiomeric Separations
• Ionic Liquids
• +۵ مورد دیگر

Daniel W Armstrong is a Professor at the University of Texas at Arlington in the Department of Chemistry and Biochemistry. With over 35 years of experience, he is a pioneering figure in chiral recognition, enantiomeric separations, and the biological relevance of D-amino acids. His work has led to over 740 publications, 35 patents, and 560 invited seminars worldwide. Developed first chiral recognition mechanism by cyclodextrins First to use macrocyclic antibiotics as chiral selectors Synthesized most new ionic liquids (ILs) globally Created ultra-fast separation techniques now standard in analytical chemistry Contributed to FDA 1992 guidelines on chiral drug separation His research focuses on chiral separations, ionic liquids, and the role of D-amino acids in biological systems. He has commercialized over 30 HPLC and GC columns, transforming analytical chemistry and pharmaceutical analysis. Recent publications demonstrate continued innovation in chiral chromatography, biomarker analysis, and AI-driven separation optimization. His grants include industry collaborations with Merck, Alcon, and Sigma-Aldrich, emphasizing practical applications of his work. Scientific honors include multiple lifetime achievement awards, fellowships in the Royal Society of Chemistry and American Chemical Society, the Chirality Medal, and induction into the National Academy of Inventors. He has mentored over 100 PhD students, many from first-generation college backgrounds.

Poul Henning Jensenمشاهده پروفایل

استاد

• Neurobiology
• Parkinson's Disease
• Synucleinopathies
• +۴ مورد دیگر

Poul Henning Jensen is a full Professor at Aarhus University , affiliated with both the Department of Biomedicine (Skou-building) and the Department of Molecular Biology and Genetics (Neurobiology section). Research Interests : Neurobiology of synucleinopathies Molecular mechanisms in Parkinson's disease Protein aggregation and propagation Calcium signaling in neurodegeneration Neuroinflammatory responses Scientific Activities : His work focuses on α-synuclein biology, covering structural analysis, aggregation pathways, and their pathological consequences. Recent studies include novel detection methods for early α-synuclein pathology mechanisms of neurotoxicity sex-specific neuroprotective factors and protein interaction networks in disease models . Scientific Awards : Recipient of at least one significant research prize Collaborations : Works with international teams on clinical trials targeting α-synuclein and coordinates multiple studies on neurodegenerative disease mechanisms.

• Synthetic Biology
• Chemical Biology
• Chemical Medicine
• +۹ مورد دیگر

Ben Davis is a Professor of Chemical Biology at the University of Oxford and Science Director for Next Generation Chemistry at the Rosalind Franklin Institute . He obtained his BA (1993) and DPhil (1996) at Oxford under Professor George Fleet, followed by postdoctoral work at the University of Toronto. Research Focus: His work bridges carbohydrate chemistry and protein engineering , emphasizing synthesis methodologies , biocatalysis , enzyme mechanisms , and glycobiology . Key applications include drug delivery , molecular imaging , and plant productivity via SugaROx. Recent Publications highlight advancements in cryo-EM structure determination , NMR pulse calculation , protein acylation , ALS therapeutics , and agricultural biotechnology . These reflect his interdisciplinary approach spanning synthetic chemistry, structural biology, and translational applications. Scientific Leadership: Elected Fellow of the Royal Society (2015) TR35 Innovator (MIT Technology Review, 2003) BBSRC Innovator Finalist (2010) Editorial leadership in Chemical Science , ChemBioChem , and others Co-founder of biotech ventures: Glycoform, Oxford Contrast, SugaROx, Scindo